Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression

Am J Pathol. 2018 Oct;188(10):2378-2391. doi: 10.1016/j.ajpath.2018.06.021. Epub 2018 Aug 1.

Abstract

Medullary breast carcinoma (MBC) is a rare subtype of triple-negative breast cancer with specific genomic features within the spectrum of basal-like carcinoma (BLC). In this study of 19 MBCs and 36 non-MBC BLCs, we refined the transcriptomic and genomic knowledge about this entity. Unsupervised and supervised analysis of transcriptomic profiles confirmed that MBC clearly differs from non-MBC BLC, with 92 genes overexpressed and 154 genes underexpressed in MBC compared with non-MBC BLC. Immunity-related pathways are the most differentially represented pathways in MBC compared with non-MBC BLC. The proapoptotic gene BCLG (official name BCL2L14) is by far the most intensely overexpressed gene in MBC. A quantitative RT-PCR validation study conducted in 526 breast tumors corresponding to all molecular subtypes documented the specificity of BCLG overexpression in MBC, which was confirmed at the protein level by immunohistochemistry. We also found that most MBCs belong to the immunomodulatory triple-negative breast cancer subtype. Using pan-genomic analysis, it was found that MBC harbors more losses of heterozygosity than non-MBC BLC. These observations corroborate the notion that MBC remains a distinct entity that could benefit from specific treatment strategies (such as deescalation or targeted therapy) adapted to this rare tumor type.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA2 Protein / genetics
  • Carcinoma, Medullary / genetics*
  • DNA, Neoplasm / metabolism
  • Female
  • Gene Expression Profiling
  • Genes, Neoplasm / genetics
  • Humans
  • Loss of Heterozygosity / genetics
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • RNA, Neoplasm / metabolism
  • Retrospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • Triple Negative Breast Neoplasms / genetics*
  • Ubiquitin-Protein Ligases / genetics

Substances

  • BCL2L14 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • DNA, Neoplasm
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Neoplasm
  • BRAP protein, human
  • Ubiquitin-Protein Ligases